(A) Boxplots (median, 25th and 75th percentiles, whiskers extend to most extreme point within median ±1.5 x IQR) of the number of viral genomes per microliter transport media stratified by day post …
Titers and day of sampling for all samples processed from the cohort.
The number of iSNV and day of sampling for samples that qualified for iSNV identification.
The number of iSNV and vaccination status for samples that qualified for iSNV identification.
Location and frequency of iSNV identified in each individual.
(The highest quality sample was used when two where available).
For each sample, the sliding window mean coverage was calculated using a window size of 200 and a step of 100. The distributions of these means are plotted as box plots (median, 25th and 75th …
The branches are colored by season; the tip identifiers are colored by household. Arrows with numbers indicate consensus and putative minor haplotypes for samples with greater than 10 iSNV. Trees …
The branches are colored by season; the tip identifiers are colored by household. Arrows with numbers indicate consensus and putative minor haplotypes for samples with greater than 10 iSNV. Trees …
(A) The number of iSNV identified in an isolate (y-axis) plotted against the titer (x-axis, genomes/μl transport media).
(A) Histogram of within-host iSNV frequency in 249 high quality samples. Bin width is 0.05 beginning at 0.02. As in Figure 1, mutations were classified as nonsynonymous (blue) if they were …
The frequency and class (nonsynonymous/synonymous) of identified iSNV.
Meta data for nonsynonymous iSNV found in HA.
Frequency and meta data for antigenic iSNV that were also identified at the global level.
Sampling day for within-host sample pairs.
Frequencies of mutations identified in longitudinal sample pairs.
The x-axis represents iSNV frequencies found in the home-acquired nasal swab. The y-axis represents iSNV frequencies found the clinic-acquired combined throat and nasal swab. Dashed line is a one to …
(A) The distribution of pairwise L1-norm distances for household (blue) and randomly-assigned community (gold) pairs. The bar heights are normalized to the height of the highest bar for each given …
Genetic distance of household and community sample pairs.
Day of onset and meta data for transmission pairs.
Frequencies of iSNV identified in transmission pairs.
The model prediction of the probability of transmission given donor frequency for the presence-absence model.
The frequency of donor iSNV used in fitting transmission models.
The model prediction of the probability of transmission given donor frequency for the beta-binomial model.
Bottleneck estimates for all isolate pairings in cases where multiple donor or recipient isolates are available.
SPECID refers to specimen ID. Those beginning in M were taken at the clinic. Those beginning with HS were isolated at home.
(A) The frequency of iSNV in both recipient and donor isolates. iSNV were identified using the original variant calling pipeline as in (McCrone and Lauring, 2016). (B) The presence-absence model fit …
2010–2011 | 2011–2012 | 2012–2013 | 2013–2014 | 2014–2015 | |
---|---|---|---|---|---|
Households | 328 | 213 | 321 | 232 | 340 |
Participants | 1441 | 943 | 1426 | 1049 | 1431 |
Vaccinated, n (%)* | 934 (65) | 554 (59) | 942 (66) | 722 (69) | 992 (69) |
IAV Positive Individuals† | 86 | 23 | 69 | 48 | 166 |
H1N1 | 26 | 1 | 3 | 47 | 0 |
H3N2 | 58 | 22 | 66 | 1 | 166 |
IAV Positive Households‡ | |||||
Two individuals | 13 | 2 | 9 | 7 | 23 |
Three individuals | 5 | 2 | 3 | 3 | 11 |
Four individuals | - | - | 1 | 2 | 4 |
High Quality NGS Pairs§ | 4 | 1 | 2 | 6 | 39 |
*Self reported or confirmed receipt of vaccine prior to the specified season.
†RT-PCR confirmed infection.
‡Households in which two individuals were positive within 7 days of each other. In cases of trios and quartets, the putative chains could have no pair with onset > 7 days apart.
§Samples with > 103 genome copies per µl of transport medium, adequate amplification of all eight genomic segments, and average sequencing coverage > 103 per nucleotide.
Sensitivity and specificity of variant detection
Nonsynonymous substitutions in HA antigenic sites
Estimated bottleneck size for individual transmission pairs